Even if that were worst case scenario Nadar is now gone so it would not have any negative effect if anything positive. However if partnership/buyout it would obviously be huge for SP. It’s all about the timing id this happened 2 momths ago or even a month ago i wouldn’t relate it to the cancelled conference call or the NASH 700 mg data. Also hospitalizations in Brazil picking way up i think Big Pharma knows there window of opportunity quickly closing for them to get best price buyout.